“…25 Data from the National Inpatient Sample (NIS) database from 2012-2014 has shown that complete heart block is more prevalent among patients with sarcoidosis compared to those without a diagnosis of sarcoidosis and increased the odds of developing complete heart block among other medical comorbidities like coronary artery disease, age, gender and heart failure. 26 A recent Finnish study of 325 cases of cardiac sarcoidosis from the Myocardial Inflammatory Diseases in Finland Study Group Registry diagnosed from 1988 to 2015, reports that 143 (44%) patients presented with Mobitz II second degree or third degree AVB in the absence of other explanatory cardiac disease. 27 Likewise, another Finnish study of 72 patients aged <55 presenting with new-onset, unexplainable Mobitz II second degree or third degree AVB, 14 of 72 (19%) patients had histologically confirmed CS whilst another 4 (6%) had giant cell myocarditis.…”